<SEC-DOCUMENT>0001104659-21-034763.txt : 20210311
<SEC-HEADER>0001104659-21-034763.hdr.sgml : 20210311
<ACCEPTANCE-DATETIME>20210311080228
ACCESSION NUMBER:		0001104659-21-034763
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20210311
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210311
DATE AS OF CHANGE:		20210311

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lipocine Inc.
		CENTRAL INDEX KEY:			0001535955
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				990370688
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36357
		FILM NUMBER:		21731899

	BUSINESS ADDRESS:	
		STREET 1:		675 ARAPEEN DRIVE, SUITE 202
		CITY:			SALT LAKE CITY
		STATE:			X1
		ZIP:			84108
		BUSINESS PHONE:		801 994 7383

	MAIL ADDRESS:	
		STREET 1:		675 ARAPEEN DRIVE, SUITE 202
		CITY:			SALT LAKE CITY
		STATE:			X1
		ZIP:			84108

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MARATHON BAR CORP
		DATE OF NAME CHANGE:	20111130
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm219307d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">UNITED STATES</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SECURITIES AND EXCHANGE COMMISSION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">WASHINGTON, D.C. 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FORM 8-K</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Pursuant to Section 13 or 15(d) of</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The Securities Exchange Act of 1934</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of Earliest Event Reported):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>March 11, 2021</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="tm219307d1_8kimg001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LIPOCINE INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in
its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Commission File No. 001-36357</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delaware</FONT></TD>
    <TD STYLE="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 39%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99-0370688</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or other jurisdiction of incorporation)</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS Employer Identification Number)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>675 Arapeen Drive, Suite 202</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Salt Lake City, Utah 84108</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices)
(Zip Code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&rsquo;s telephone number, including
area code: <B>(801) 994-7383</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Former name or former address, if changed
since last report: <B>Not Applicable</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Check the appropriate box below if the Form
8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify">Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify">Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify">Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify">Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933&nbsp;(17 CFR &sect; 230.405) or&nbsp;Rule 12b-2 of the Securities
Exchange Act of 1934&nbsp;(17 CFR &sect; 240.12b-2).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Emerging
growth company </FONT><FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to&nbsp;Section 13(a) of the Exchange Act. <FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Securities
registered pursuant to&nbsp;<U>Section 12(b)</U>&nbsp;of the Act</FONT>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-top: rgb(204,204,204) 1pt solid; border-right: rgb(204,204,204) 1pt solid; border-bottom: Black 1pt solid; border-left: #CCCCCC 1pt solid; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title of each class</FONT></TD>
    <TD STYLE="border-top: rgb(204,204,204) 1pt solid; border-right: rgb(204,204,204) 1pt solid; border-bottom: Black 1pt solid; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading Symbol(s)</FONT></TD>
    <TD STYLE="border-top: rgb(204,204,204) 1pt solid; border-right: rgb(204,204,204) 1pt solid; border-bottom: Black 1pt solid; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of each exchange on which<BR>
 registered</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid; border-left: #CCCCCC 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock, par value $0.0001 per share</FONT></TD>
    <TD STYLE="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LPCN</FONT></TD>
    <TD STYLE="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The NASDAQ Stock Market LLC</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item&nbsp;8.01</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other Events</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">On March 11, 2021, the Company issued
a press release announcing financial and operational results for the year ended December 31, 2020. The press release is filed as
Exhibit 99.1 and is incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"><B>Item 9.01</B></TD><TD><B>Financial Statements and Exhibits.</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibits</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following exhibits are filed with this report:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">Exhibit No.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">Description</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="vertical-align: top; width: 10%; font-size: 10pt; text-align: left"><A HREF="tm219307d1_ex99-1.htm" STYLE="-sec-extract: exhibit">99.1</A></TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 88%; font-size: 10pt; text-align: left"><A HREF="tm219307d1_ex99-1.htm" STYLE="-sec-extract: exhibit">Press Release announcing Financial and Operational Results for the Year Ended December 31, 2020</A></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 85.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 85.5pt"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 85.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">SIGNATURES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LIPOCINE INC.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 8%; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="width: 32%; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="width: 11%; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="width: 6%; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="width: 43%; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 11, 2021</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Mahesh V. Patel</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mahesh V. Patel</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President and Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tm219307d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"><IMG SRC="tm219307d1_ex99-1img001.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="text-transform: uppercase"><B>Lipocine
Announces Financial Results for the Year Ended December 31, 2020</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>SALT
LAKE CITY, March 11, 2021 &ndash; </B></FONT>Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on
metabolic and endocrine disorders, today announced financial results for the fourth quarter and year ended December 31, 2020, and
provided a corporate update.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&ldquo;Lipocine had a number of important
accomplishments in 2020, most notably the U.S. Food and Drug Administration (&quot;FDA&quot;) decision to grant tentative approval
to TLANDO, the Company&rsquo;s oral testosterone product for testosterone replacement therapy (&quot;TRT&quot;) in adult males
with hypogonadism. We are committed to taking action to receiving final approval to permit the launch of the product,&rdquo; said
Dr. Mahesh Patel, Chairman, President and Chief Executive Officer of Lipocine. &quot;We also made excellent progress advancing
LPCN 1144 for the treatment of non-cirrhotic non-alcoholic steatohepatitis (&ldquo;NASH&rdquo;). We were pleased with the top-line
results from our&nbsp;Phase 2 <I>LiFT</I>&nbsp;clinical study, announced in January 2021, which showed that treatment with LPCN
1144 resulted in significant liver fat reduction and improvement of key liver injury markers. The trial is on-going and we expect
36-week biopsy data in July/August 2021.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Fourth Quarter and Recent Corporate
Highlights</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>Granted tentative approval by the FDA for TLANDO, Lipocine&rsquo;s oral testosterone product for testosterone replacement therapy
(&quot;TRT&quot;) in adult males indicated for conditions associated with a deficiency or absence of endogenous testosterone</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>Announced positive topline results from the&nbsp;Phase 2 <I>LiFT</I>&nbsp;(&quot;Liver&nbsp;Fat intervention with oral&nbsp;Testosterone&quot;)
clinical study, investigating LPCN 1144 in biopsy-confirmed NASH male subjects&nbsp;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: left">Both LPCN 1144 treatment arms met the primary endpoint,
change in hepatic fat fraction via magnetic resonance imaging proton density fat fraction (&quot;MRI-PDFF&quot;), with statistical
significance</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: left">Statistically significant reduction in markers of liver
injury were observed for LPCN 1144 compared to placebo</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: left">36-week biopsy data from the&nbsp;LiFT&nbsp;study are
expected in July/August 2021</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>Began enrolling patients into an open label extension to the <I>LiFT</I> clinical study in which all patients will have access
to LPCN 1144 (no placebo arm)</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: left">The extension will allow the collection of additional
data on LPCN 1144 for up to a total of 72 weeks of therapy</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>Raised gross proceeds in January 2021 of approximately $28.7 million in a public offering of approximately 16,428,571 million
shares of common stock</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Year Ended December 31, 2020 Financial
Results</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Lipocine reported a net loss of $21.0
million, or ($0.38) per diluted share, for the year ended December 31, 2020, compared with a net loss of $13.0 million, or ($0.50)
per diluted share, for the year ended December 31, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Research and development expenses were
$9.7 million for the year ended December 31, 2020, compared with $7.5 million for the year ended December 31, 2019. The increase
in research and development expenses compared with the prior year was primarily due increases in contract research organization
and outside consulting and manufacturing costs related to the LPCN 1144 LiFT Phase 2 clinical study, an increase in commercial
manufacturing costs related to TLANDO, an increase in personnel expense, as well as a net increase in other R&amp;D programs and
expenses. Additionally, other costs related to TLANDO had a net decrease which was the result of a decrease in contract research
organization expenses, offset by increases in other TLANDO expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">General and administrative expenses
were $8.2 million for the year ended December 31, 2020, compared with $5.6 million for the year ended December 31, 2019. The increase
in general and administrative expenses compared with the prior year was primarily due to an increase in legal costs, an increase
in personnel costs, and an increase in other general and administrative expenses. These were offset by a decrease in administrative
travel expenses and marketing expense.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">As of December 31, 2020, Lipocine had
$19.7 million of unrestricted cash, cash equivalents and marketable investment securities compared to $14.1 million as of December
31, 2019. Additionally, as of December 31, 2020 and December 31, 2019 Lipocine had $5.0 million of restricted cash, which was required
to be maintained as cash collateral under the Silicon Valley Bank (&ldquo;SVB&rdquo;) Loan and Security Agreement until TLANDO
is approved by the FDA. However, on February 16, 2021, Lipocine and SVB amended the Loan and Security Agreement to, among other
things, remove the cash collateral requirement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Subsequent to the end of the year,
in January 2021, Lipocine raised gross proceeds of approximately $28.7 million in a public offering before deducting underwriting
discounts and commissions and other offering expenses payable by Lipocine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>About Lipocine Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Lipocine
Inc. is a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders using its proprietary drug delivery
technologies. Lipocine's clinical development pipeline includes: TLANDO, LPCN 1144, TLANDO XR, LPCN 1148 and LPCN 1107. TLANDO,
a novel oral prodrug of testosterone containing testosterone undecanoate, has received tentative approval from the FDA for conditions
associated with a deficiency of endogenous testosterone, also known as hypogonadism, in adult males.&nbsp;LPCN 1144, an oral prodrug
of bioidentical testosterone, recently completed a proof-of-concept clinical study demonstrating the potential utility in the
treatment of non-cirrhotic NASH.&nbsp;LPCN 1144 is currently being studied in a Phase 2 clinical study.&nbsp; TLANDO XR, a novel
oral prodrug of testosterone, originated and is being developed by Lipocine as a next-generation oral testosterone product with
potential for once-daily dosing. In a phase 2 clinical evaluation when administered as once daily or twice daily TLANDO XR met
the typical primary and secondary end points. LPCN 1148 is an oral prodrug of bioidentical testosterone targeted for the treatment
of cirrhosis. LPCN 1107 is potentially the first oral hydroxyprogesterone caproate product candidate indicated for the prevention
of recurrent preterm birth and has been granted orphan drug designation by the FDA. For more information, please visit </FONT><FONT STYLE="background-color: white"><U>www.lipocine.com</U>.
 &nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This release contains &quot;forward-looking statements&quot;
that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and include statements
that are not historical facts regarding Lipocine's product candidates and related clinical trials, the timing of completion of
clinical trials and studies, the availability of additional data, outcomes of clinical trials of our product candidates, the potential
uses and benefits of our product candidates, and our product development efforts. Investors are cautioned that all such forward-looking
statements involve risks and uncertainties, including, without limitation, the risk that the FDA will not approve any of our products,
risks related to our products, expected product benefits not being realized, clinical and regulatory expectations and plans not
being realized, new regulatory developments and requirements, risks related to the FDA approval process including the receipt
of regulatory approvals, the results and timing of clinical trials, patient acceptance of Lipocine's products, the manufacturing
and commercialization of Lipocine's products, and other risks detailed in Lipocine's filings with the SEC, including, without
limitation, its Form 10-K and other reports on Forms 8-K and 10-Q, all of which can be obtained on the SEC website at&nbsp;<U>www.sec.gov</U>.&nbsp;
Lipocine assumes no obligation to update or revise publicly any forward-looking statements contained in this release, except as
required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>CONTACT: </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Morgan Brown</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Executive Vice
President &amp; Chief Financial Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Phone: (801) 994-7383</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><U>mb@lipocine.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Investors:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Hans Vitzthum</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Phone: (617) 535-7743</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>hans@lifesciadvisors.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>LIPOCINE INC. AND SUBSIDIARIES</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Consolidated Balance Sheets</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">December 31, 2020 and 2019</FONT></P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2020</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2019</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Current assets:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; width: 72%; text-align: left">Cash and cash equivalents</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">19,217,382</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">9,728,523</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left">Restricted cash</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">5,000,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">5,000,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left">Marketable investment securities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">449,992</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4,340,041</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left">Accrued interest income</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">391</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">16,522</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left">Prepaid and other current assets</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">661,258</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">545,887</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.5in; text-align: left">Total current assets</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">25,329,023</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">19,630,973</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Property and equipment, net of accumulated depreciation of $1,143,697 and $1,140,143, respectively</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3,554</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Other assets</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">23,753</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">23,753</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.5in; text-align: left">Total assets</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">25,352,776</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">19,658,280</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Liabilities and Stockholders' Equity</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Current liabilities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left">Accounts payable</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,597,220</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,182,241</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left">Accrued expenses</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,653,178</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">449,303</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left">Debt - current portion</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,333,333</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,333,333</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.5in; text-align: left">Total current liabilities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">6,583,731</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4,964,877</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left">Debt - non-current portion</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,257,075</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3,814,407</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left">Warrant liability</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,170,051</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">4,591,200</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.5in; text-align: left">Total liabilities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">10,010,857</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">13,370,484</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Commitments and contingencies</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Stockholders' equity:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; font: 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Preferred stock, par value $0.0001 per share, 10,000,000 shares authorized; zero issued and outstanding</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; font: 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Common stock, par value $0.0001 per share, 100,000,000 shares authorized; 70,041,967 and 37,655,175 issued and 70,036,257 and 37,649,465 outstanding</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">7,005</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3,766</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left">Additional paid-in capital</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">187,407,634</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">157,391,969</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left">Treasury stock at cost, 5,710 shares</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(40,712</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(40,712</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left">Accumulated other comprehensive loss</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(38</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left">Accumulated deficit</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(172,032,008</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(151,067,189</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.5in; text-align: left">Total stockholders' equity</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">15,341,919</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">6,287,796</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.5in; text-align: left">Total liabilities and stockholders' equity</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">25,352,776</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">19,658,280</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>LIPOCINE INC. AND SUBSIDIARIES</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated
Statements of Operations and Comprehensive Loss</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Years Ended December 31, 2020 and 2019</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2020</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2019</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Revenues:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; width: 72%; text-align: left">License revenue</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">164,990</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left">Total revenues</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">164,990</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Operating expenses:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Research and development</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">9,748,469</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">7,468,210</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">General and administrative</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">8,247,795</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">5,597,070</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left">Total operating expenses</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">17,996,264</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">13,065,280</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left">Operating loss</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(17,996,264</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(12,900,290</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Other income (expense)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Interest and investment income</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">75,650</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">423,491</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Interest expense</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(386,618</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(766,745</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Gain on extinguishment of debt</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">234,802</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Unrealized gain (loss) on warrant liability</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,892,189</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">236,400</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left">Total other expense, net</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,968,355</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(106,854</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left">Loss before income tax expense</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(20,964,619</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(13,007,144</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Income tax expense</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(200</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(200</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left">Net loss</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(20,964,819</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(13,007,344</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Basic loss per share attributable to common stock</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.38</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.50</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Weighted average common
    shares outstanding, basic</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">55,688,085</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">25,882,273</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Diluted loss per share attributable to common stock</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.38</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.50</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Weighted average common shares outstanding, diluted</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">55,688,085</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">25,882,273</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Comprehensive loss:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left">Net loss</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(20,964,819</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(13,007,344</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left">Unrealized net gain on available-for-sale securities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">38</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">925</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left">Comprehensive loss</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(20,964,781</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(13,006,419</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tm219307d1_8kimg001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm219307d1_8kimg001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !5 /L# 2(  A$! Q$!_\0
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M.@>$.N0PC2*(NRY"Y8$Y1@'?MN^$+3XS?\%M_@W\#K[.H>$_AO!X<\+&U?\
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M .VO-^P?VM?);?:_*V>9LW$;MOF1YQTWCUK@_P#AZ+^SI_T6OX;_ /@\@_\
MBJ />:*\&_X>B_LZ?]%K^&__ (/(/_BJ]F\&>,])^(OA/3]=T+4+35M&U:!+
MJRO;6020W43C*NC#@J1R"* %E\&Z//XFCUI]*TU]9AC\F._:U0W*)R-HDQN
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MWXB_M!?!3X'V7@CP5XD\5W>A_;/[0ATRQ>X>SW06JKY@4';DHPY_NFOU&HH
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MWC_P5?\ ^A"\<?\ AMK?_P",5^^]%!29^!'_  WC_P %7_\ H0O''_AMK?\
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MH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
6HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>tm219307d1_ex99-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm219307d1_ex99-1img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 B17AI9@  34T *@    @  0$2  ,
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MU]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0
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MLVCFVM=9O;1?GTZ\MY0UE=O[,"(B3\H,42GE^0#]?J*^+?\ @EE_P6(\(_\
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M-Z9<VFHZ=I+7MO:W]MJE[<(K?*5)7,3%3U##(P:_7ZC.* /Q-_X;0_X*8?\
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M\,/AKXJT+PKXB&BWOB/5]4U)()([2)8VBL;?;,=O^D71^; W+'"Y&,YKUO\
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M_:'^'?CQ=46U7P';ZK;FR-MO^V_;8X$R)-PV;/)S]UMV[MCG#_; _9P\0?M
MVO@>Z\+>*-/\*:[X'\0KK]K=7NDG4H)&%K<6^QHA+%_S\;L[OX>E=494>>.E
ME;6_?7R].AY%6CCEAZJO>;DG&VFEHWLKZ;/2ZO\ ,I_LK?M!:#\:_$.J1:+X
MN^(7B!K&W5Y8?$7A8Z/#&&; =':QMB[?*1@,V >1T(C_ &Y_VB=0^"WA+PSX
M?\-ZEI^F^-/B'K,6BZ5=W>QH]-BSYEW>LCC:RP0*QPW!=XP<YP=[X$_#_P"+
M7A'Q'=3_ ! ^(7A?Q9I<EMLM[73/"S:5)#-N4^89#<R[EVAAMVCE@<\8./\
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M?M5W'[+OQ'^#\TUW=V_ACQ%KMY9Z['::5)J-Q<0IIUS+&J1Q1O+D3+&28QG
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5HH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
